Abstract:Purpose Adverse drug events (ADEs) are a significant global public health concern, and they have resulted in high rates of hospital admissions, morbidity, and mortality. Prior to the use of machine learning and deep learning methods, ADEs may not become well recognized until long after a drug has been approved and is widely used, which poses a significant challenge for ensuring patient safety. Consequently, there is a need to develop computational approaches for earlier identification of ADEs not detected during pre-registration clinical trials. Methods This paper presents a state-of-the-art network-based approach that models patients as subgraphs composed of nodes of International Classification of Diseases (ICD) codes and directed edges illustrating disease progression. Four Graph Neural Network (GNN) variants were employed to make sub-graph level predictions that answer three Research Questions (RQ): 1) whether ADE(s) would occur given a patient's prior diagnoses history, 2) when an ADE would occur, and 3) which ADE would occur. The first and second RQs were addressed using a binary classification approach. The third RQ was addressed using a multi-label classification model. Results The proposed network-based approach demonstrated superior performance in predicting ADEs, with the GraphSage model exhibiting the highest accuracy for both RQ 1 (0.8863) and RQ 3 (0.9367), while the Graph Attention Networks (GAT) model was found to perform best for RQ 2 (0.8769). Furthermore, an analysis segmented by ADE classification revealed that while RQs 1 and 3 exhibited minimal variance across different ADE categories, a distinct advantage was observed for categories B, C, and E in the context of RQ 2 when applying this sub-graph method. Conclusion The network-based approach demonstrates the potential of GNNs in supporting the early detection and prevention of ADEs. Accurately predicting ADEs could enable healthcare professionals to make informed clinical decisions, take preventive measures and adjust medication regimens before serious adverse events occur. The proposed prediction method could also lead to optimized usage of healthcare resources by preventing hospital admissions and reducing the overall burden of adverse drug events on the healthcare systems.

T helper cell subsets in insulin-dependent diabetes.

A novel interactive deep cascade spectral graph convolutional network with multi-relational graphs for disease prediction

Graph Neural Networks for Heart Failure Prediction on an EHR-Based Patient Similarity Graph

Investigation of Customized Medical Decision Algorithms Utilizing Graph Neural Networks

Graph neural network-based subgraph analysis for predicting adverse drug events

A Systematic Review of Graph Neural Network in Healthcare-Based Applications: Recent Advances, Trends, and Future Directions

The reliable distributed network management platform

A systematic review of networks for prognostic prediction of health outcomes and diagnostic prediction of health conditions within Electronic Health Records

Graph neural networks for clinical risk prediction based on electronic health records: A survey

DNA-based magnetic nanoparticle assembly acts as a magnetic relaxation nanoswitch allowing screening of DNA-cleaving agents.

Heterogeneous graph construction and HinSAGE learning from electronic medical records

A Generative Framework for Predictive Modeling of Multiple Chronic Conditions Using Graph Variational Autoencoder and Bandit-Optimized Graph Neural Network

A Laplacian regularized graph neural network for predictive modeling of multiple chronic conditions

Graph AI in Medicine

A hybrid method of recurrent neural network and graph neural network for next-period prescription prediction

Graph data modelling for outcome prediction in oropharyngeal cancer patients

Graph representation forecasting of patient's medical conditions: towards a digital twin

Preconsultation education promoting breast cancer screening: does the choice of media make a difference?

Self-explainable Graph Neural Network for Alzheimer's Disease And Related Dementias Risk Prediction

Pre-training graph neural networks for link prediction in biomedical networks

Comparisons of Graph Neural Networks on Cancer Classification Leveraging a Joint of Phenotypic and Genetic Features